Carrageenan-Induced Inflammatory Pain
CFA Induced Inflammatory Pain
Chemotherapy-Induced Neuropathic Pain
Chronic Post-Ischemia Pain
Collagen-Induced Arthritis
EAE
MIA Induced Osteoarthritis
Neurite Outgrowth Assay
Neurodegeneration Screening Assay
Neuroma
Symptomatic Neuroma
Parkinson's Disease
Peripheral Nerve Injury
Peripheral Nerve Repair
Neuropathic Pain
Post-Operative Pain
Spinal Cord Injury
Stroke and Ischemia
STZ-Induced Diabetic Neuropathic Pain
Wound Healing
Cortical Trauma Injury Model
ZDF Model
Cuprizone Model
Jul 14, 2026by MD Biosciences
AAALAC accreditation carries practical weight in preclinical drug development, and its implications for program quality...
Jul 7, 2026by MD Biosciences
Botulinum toxin type A has been established as a therapeutic agent in spasticity, dystonia, and cosmetic indications...
Jun 30, 2026by MD Biosciences
Spinal cord injury presents one of the most challenging translational profiles in central nervous system drug...
Jun 23, 2026by MD Biosciences
GLP-1 receptor agonists have substantially reshaped the therapeutic landscape for type 2 diabetes and obesity, and the...
Jun 16, 2026by MD Biosciences
Drug development for chronic kidney disease has entered a more ambitious phase. SGLT2 inhibitors, non steroidal...
.png?width=317&height=317&name=Kidney%20Injury%20Image%20(2).png)
.png?width=600&height=600&name=Nerve%20injury%20datasheet%20(1).png)
.png?width=600&height=600&name=Wound%20Healing%20datasheet%20(1).png)
